SCHEDULE: Mizuho Financial Group Reports Zero Stake in Aimei Health Tech

Sentiment:

Beneficial Ownership Report


Mizuho Financial Group, Inc. filed an Amendment No. 3 to Schedule 13G, reporting zero beneficial ownership in Aimei Health Technology Co., Ltd. as of December 31, 2025.

Summary

  • Mizuho Financial Group, Inc. (Mizuho) filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership in Aimei Health Technology Co., Ltd.
  • Mizuho reported 0.00 shares beneficially owned, representing 0.0% of Aimei Health Technology Co., Ltd.'s Common Shares.
  • Mizuho Financial Group, Inc., Mizuho Bank, Ltd., and Mizuho Americas LLC may be deemed indirect beneficial owners of equity securities directly held by Mizuho Securities USA LLC, a wholly-owned subsidiary.
  • The securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine regulatory filing indicating Mizuho Financial Group's current lack of reportable beneficial ownership in Aimei Health Technology Co., Ltd.

Future Outlook

NA

Management Comments

  • The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
  • The foreign regulatory scheme applicable to Parent Holding Company is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s).

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors holding less than 20% of a company's shares, primarily for passive investment purposes. A zero ownership report indicates a complete divestment or never reaching the reporting threshold, which is a standard part of portfolio management.

Key Dates

DateDescription
12/31/2025Date of event requiring the filing of this statement.
02/12/2026Date of signature for Mizuho Financial Group, Inc. on the Schedule 13G.
02/12/2026Date of signature for Mizuho Bank, Ltd. on the Power of Attorney.
02/12/2026Date of signature for Mizuho Americas LLC on the Power of Attorney.
02/12/2026Date of signature for Mizuho Securities USA LLC on the Power of Attorney.

Keywords

Aimei Health Technology, Mizuho Financial Group, Schedule 13G, beneficial ownership, common shares, SEC filing, institutional ownership, financial services

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.